Opioids
The opioid epidemic has been an incredibly challenging public health crisis in communities across our country. And it’s clear the COVID-19 pandemic has exacerbated the challenges.
State attorneys general announced a $26 billion proposed settlement with Johnson & Johnson and distributors McKesson, Cardinal Health and Amerisource Bergen over the companies’ alleged role in creating and fueling the opioid epidemic.
AHA member organizations are undertaking a variety of efforts to address opioid issues in their communities. Hear examples of some of those efforts from Alicia Mikolaycik Gonzalez, M.D., regional director at the Oakland, Calif.-based CA Bridge Program.
Strategies for opioid stewardship. This Transformation Talks video explores steps providers can take to help address the opioid crisis.
Although COVID-19 has been a significant contributor to the substance abuse epidemic, it does not explain the large number of drug overdose deaths between May 2019 and May 2020 — the most ever recorded in a 12-month period, writes Holly Geyer, M.D., hospital internal medicine practitioner at Mayo…
If there has ever been a time for opioid stewardship, it’s now. Between May 2019 and May 2020, the United States had the highest number of drug overdose deaths ever recorded in a 12-month period. Synthetic opioids were the primary driver for this increase with a 38% rise in deaths over the…
The Department of Health and Human Services released new practice guidelines for administering buprenorphine, which exempt from certain training and certification requirements eligible physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and…
Access to behavioral health care unfortunately remains difficult due to the shortage of providers, stigma, lack of a true connected continuum of care, and more. This series of case studies featuring the innovative work of hospitals and health systems and their community partners, details how…
The Centers for Medicare & Medicaid Services has selected 61 applicants for the Value in Opioid Use Disorder Treatment Demonstration, a four-year Medicare payment model beginning this month for selected health care providers who agree to participate.
Public health departments that receive certain federal grants to prevent opioid overdoses can now use those funds to purchase fentanyl test strips, the Centers for Disease Control and Prevention and Substance Abuse and Mental Health Services Administration announced.